Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$2.01 - $5.95 $506,117 - $1.5 Million
-251,800 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$8.22 - $11.2 $609,948 - $831,073
74,203 Added 41.78%
251,800 $2.1 Million
Q2 2019

Aug 14, 2019

BUY
$10.05 - $14.25 $1.1 Million - $1.56 Million
109,780 Added 161.88%
177,597 $2.01 Million
Q4 2018

Feb 11, 2019

BUY
$10.8 - $17.94 $562,464 - $934,315
52,080 Added 330.94%
67,817 $859,000
Q3 2018

Nov 14, 2018

BUY
$10.92 - $18.18 $171,848 - $286,098
15,737 New
15,737 $284,000

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.